Atlas Trials

Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease

Clinical trial NCT07247188 · RECRUITING

Trial details

NCT number
NCT07247188
Sponsor
Sanofi
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2026-01-20
Primary completion
2027-01-07
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.